Skip to main content

Table 3 Late adverse events (n = 20)

From: Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes

Events

Distribution and%

Small bowel obstruction *

3 (15%)

Sigmoid perforation*

1 (5%)

Chronic radiation enteritis and proctitis CTC 1

1 (5%)

Radiation pneumonitis CTC 1

1 (5%)

Vaginal dryness and teleangiectasia

3 (15%)

Dyspareunia

1 (5%)

Urinary urgency CTC 1

1 (5%)

Chronic fatigue

3 (15%)

Chronic neuropathy CTC 2

2 (10%)

Chronic leg oedema

1 (5%)

Tight cellulitis

1 (5%)

Infected lymphocele

1 (5%)

Renal failure**

1 (5%)

Erosive gastritis

1 (5%)

  1. * all in the context of recurrent intraperitoneal recurrent disease.
  2. **Attributed to severe type II diabetic nephropathy, did not receive chemo because of severe diabetes.
  3. Some patients have >1 adverse event.